Sermorelin Benefits: What the Research Shows
Last reviewed
Sermorelin is often marketed to adults for energy, body composition and "anti-aging." Its established medical use is much narrower. Here's what the research supports.
The short version
- Sermorelin is a growth-hormone-releasing peptide. Its documented medical use is in children with growth hormone deficiency.
- Adult evidence is small and short, and the best-designed study used a closely related molecule.
- Published sources disagree on its current FDA and compounding status, and it's banned for tested athletes.
Evidence at a glance
| Use | What exists |
|---|---|
| Children with growth hormone deficiency | Established Used for diagnosis and treatment; reviewed in 1999. |
| Healthy older adults | Small studies A few short trials, some using closely related GHRH analogs. |
| Muscle building, anti-aging | Not established Not an approved use; the FDA hasn't authorized growth hormone itself for these. |
What sermorelin is
Sermorelin is a synthetic 29-amino-acid version of growth-hormone-releasing hormone (GHRH), the shortest fragment with GHRH's full activity. It works by prompting the pituitary gland to release the body's own growth hormone, rather than supplying growth hormone directly.
Its established use: children with growth hormone deficiency
A 1999 review describes sermorelin's use in diagnosing and treating children with idiopathic growth hormone deficiency. Given into a vein, it works as a test of whether the pituitary can release growth hormone; given nightly under the skin, it was used to promote growth.
What adult studies show
The most informative adult trial we found used a closely related analog, [Nle27]GHRH(1-29). In this 1997 placebo-controlled study, 19 adults aged 55 to 71 injected it nightly for 16 weeks:
- Growth hormone and IGF-1 levels rose.
- Skin thickness increased in both men and women.
- Lean body mass, insulin sensitivity, general well-being and libido improved in men, but not in women.
- Body weight and bone density didn't change; the only side effect noted was a temporary rise in blood fats.
It's one small study of a different molecule. A 2006 editorial argued that GHRH-based treatment like sermorelin might be a better approach than growth hormone itself for adults with low growth hormone, but that's an opinion piece, not new trial data.
FDA status and sports rules
Published sources disagree on sermorelin's current FDA and compounding status, so it isn't on our FDA status tracker yet. If it's prescribed to you, your prescription label and pharmacist are the authority. For athletes, the 2026 World Anti-Doping Code Prohibited List names sermorelin as a growth-hormone-releasing hormone analogue in class S2, prohibited at all times.
Frequently asked questions
What does sermorelin do?
It prompts the pituitary gland to release growth hormone. It has been used to diagnose and treat growth hormone deficiency in children.
What are the benefits of sermorelin for adults?
Limited evidence. In a small 1997 study of a closely related analog, older men gained lean body mass and insulin sensitivity; women didn't.
Is sermorelin banned in sports?
Yes, class S2 on the 2026 WADA list, prohibited at all times.
How is sermorelin mixed?
It comes as a powder that's reconstituted before use. Our sermorelin reconstitution calculator does the arithmetic. If it was prescribed, follow your pharmacy's instructions.
Sources
- Prakash and Goa, Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency, BioDrugs (1999)
- Khorram, Laughlin and Yen, Endocrine and metabolic effects of long-term [Nle27]GHRH(1-29)-NH2 in age-advanced men and women, Journal of Clinical Endocrinology and Metabolism (1997)
- Walker, Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging (2006)
- FDA Import Alert 66-71: Unapproved human growth hormone
- The 2026 Prohibited List, World Anti-Doping Code (official Dutch government publication)